ArticleJournal of multidisciplinary healthcare2026
Analysis of Factors Related to Constipation in Hospitalised Patients with Schizophrenia: A Study from Wuhan, China.
Article in Journal of multidisciplinary healthcare, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To investigate the factors associated with constipation in patients with schizophrenia. Methods: This retrospective study analysed medical records of hospitalised patients with schizophrenia admitted to a psychiatric department in Wuhan between January and December 2023. Demographic and clinical data were collected and cross-checked by psychiatrists. Logistic regression analysis was used to identify independent risk factors. Results: Among 904 patients, 268 (29.65%) had constipation, including incomplete intestinal obstruction (5.97%), anal fissures (20.89%) and haemorrhoids (38.10%). The prevalence was higher in women (33.59%) than in men (26.73%). Multivariate logistic regression identified poverty (odds ratio [OR] = 1.60, 95% CI: 1.14-2.23, P = 0.006), disease duration ≥10 years (OR = 4.13, 95% CI: 2.41-7.07, P < 0.001), clozapine use (OR = 2.56, 95% CI: 1.67-3.94, P < 0.001), combined drug therapy (OR = 2.58, 95% CI: 1.67-3.99, P < 0.001), comorbid anxiety disorders (OR = 2.64, 95% CI: 1.79-3.88, P < 0.001), comorbid hypertension (OR = 3.84, 95% CI: 2.73-5.39, P < 0.001), dyslipidaemia (OR = 1.81, 95% CI: 1.21-2.71, P = 0.004) and smoking (OR = 1.57, 95% CI: 1.13-2.20, P = 0.008) as independent risk factors. Subgroup analyses showed stronger associations between clozapine and constipation in women and between long disease duration and constipation in older patients. Conclusion: The prevalence of constipation in patients with schizophrenia is high. For high-risk groups with the above factors, early intervention should be implemented to prevent the onset of constipation and improve patients' quality of life.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.